英文、和文論文

英文論文

 

1. Effectiveness of the direct renin inhibitor, aliskiren, in patients with resistant hypertension. 

Yoshitomi Y, Kawanishi K, Yamaguchi A, Sakurai S, Minai K, Ishii T, Tarutani Y, Tsujibayashi T, Kaneki M, Saitou Y, Suwa S.

Int Heart J. 2013;54(2):88-92.

 

2. Significance of pulsatility of brachial artery pressure for blood pressure control.

Yoshitomi Y, Ishii T, Tsujibayashi T, Kaneki M, Sakurai S.

Int Heart J. 2008 May;49(3):295-302.

 

3. Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study.

Yoshitomi Y, Ishii T, Kaneki M, Tsujibayashi T, Sakurai S, Nagakura C, Miyauchi A.

J Atheroscler Thromb. 2006 Apr;13(2):108-13.

 

4. Significance of mean blood pressure for blood pressure control.

Yoshitomi Y, Nagakura C, Miyauchi A.

Int Heart J. 2005 Jul;46(4):691-9.

 

5. Relationship between insulin resistance and effect of atorvastatin in non-diabetic subjects.

Yoshitomi Y, Ishii T, Kaneki M, Tsujibayashi T, Sakurai S, Nagakura C, Miyauchi A.

J Atheroscler Thromb. 2005;12(1):9-13.

 

6. Relation of pulsatility of brachial artery pressure to resistant hypertension.

Yoshitomi Y, Nagakura C, Miyauchi A.

Hypertens Res. 2004 Sep;27(9):641-6.

 

7. Related factors of meeting National Cholesterol Education Program-recommended goals with atorvastatin.

Yoshitomi Y, Tsujibayashi T, Ishii T, Sakurai S, Nagakura C, Miyauchi A;

J Atheroscler Thromb. 2003;10(1):19-24.

 

8.Peristent tissue proliferation of multilink stents is dependent on preprocedural plaque area: a serial intravascular ultrasound analysis.

Yoshitomi Y, Kojima S, Yano M, Matsumoto Y, Sugi T, Saotome M, Tanaka KE, Endo M, Kuramochi M.

Angiology. 2002 May-Jun;53(3):303-11.

 

9. Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents.

Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Saotome M, Tanaka K, Endo M, Kuramochi M.

Am Heart J. 2001 Sep;142(3):445-51.

 

10. Long-term effects of bisoprolol compared with imidapril on left ventricular remodeling after reperfusion in acute myocardial infarction: an angiographic study in patients with maintained vessel patency.

Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Kuramochi M.

Am Heart J. 2000 Dec;140(6):E27.

 

11. Relation between stent expansion and arterial remodeling: a serial intravascular ultrasound study.

Yoshitomi Y, Kojima S, Yano M, Matsumoto Y, Sugi T, Saotome M, Tanaka K, Endo M, Kuramochi M.

Catheter Cardiovasc Interv. 2000 Jul;50(3):282-9.

 

12. Acute myocardial infarction in a discrete coronary artery aneurysm without obstruction.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

J Interv Card. 2000;13(3):215.

 

13.Coronary artery spasm induced by ergonovine in an infarct related coronary artery late after primary angioplasty.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

J Interv Card. 2000;13(1):31.

 

14. A retrospective study of late outcome in patients with peripheral arterial occlusive disease: an association between prosthetic vascular graft and cancer death?

Yoshitomi Y, Kojima S, Umemoto T, Hosoi Y, Kuramochi M.

Angiology. 1999 Dec;50(12):1007-15.

 

15. Long-term effect of a new oral prostacyclin analogue, beraprost sodium, in isolated peripheral pulmonary artery stenosis in the adult.

Yoshitomi Y, Kojima S, Kuramochi M.

J Intern Med. 1999 Aug;246(2):227-30.

 

16. Serum hepatocyte growth factor in patients with peripheral arterial occlusive disease.

Yoshitomi Y, Kojima S, Umemoto T, Kubo K, Matsumoto Y, Yano M, Sugi T, Kuramochi M.

J Clin Endocrinol Metab. 1999 Jul;84(7):2425-8.

 

17. Benefit of intravascular ultrasound in Wiktor stent implantation.

Yoshitomi Y, Kojima S, Yano M, Sugi T, Matsumoto Y, Kuramochi M.

Catheter Cardiovasc Interv. 1999 May;47(1):28-35.

 

18. Echocardiography of a right atrial mass in hepatocellular carcinoma.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Ozeki Y, Kuramochi M.

Heart Vessels. 1998;13(1):45-8.

 

19. Antiplatelet treatment with cilostazol after stent implantation.

Yoshitomi Y, Kojima S, Sugi T, Yano M, Matsumoto Y, Kuramochi M.

Heart. 1998 Oct;80(4):393-6.

 

20. Plasma natriuretic peptides as indicators of left ventricular remodeling after myocardial infarction.

Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Kangawa K, Matsuo H.

Int J Cardiol. 1998 Apr 1;64(2):153-60.

 

21. Progressive renal failure in POEMS syndrome.

Yoshitomi Y, Kawano Y, Kojima S, Murakami K, Matsuoka H, Imakita M, Yutani C, Omae T.

Nephron. 1998;79(3):377-8.

 

22. Coronary vasoreactivity to ergonovine after angioplasty: difference between the infarct-related coronary artery and the noninfarct-related coronary artery.

Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

Coron Artery Dis. 1998;9(2-3):105-11.

 

23. Acute renal failure in accidental hypothermia of cold water immersion.

Yoshitomi Y, Kojima S, Ogi M, Kuramochi M.

Am J Kidney Dis. 1998 May;31(5):856-9.

 

24. Acute myocardial infarction with simultaneous occlusions of two major coronary arteries in a young man.

Yoshitomi Y, Kojima S, Kuramochi M.

Clin Cardiol. 1998 Feb;21(2):140-2.

 

25. Plasma levels of adrenomedullin in patients with acute myocardial infarction.

Yoshitomi Y, Nishikimi T, Kojima S, Kuramochi M, Takishita S, Matsuoka H, Miyata A, Matsuo H, Kangawa K.

Clin Sci (Lond). 1998 Feb;94(2):135-9.

 

26. Left ventricular systolic and diastolic function and mass before and after antihypertensive treatment in patients with essential hypertension.

Yoshitomi Y, Nishikimi T, Abe H, Nagata S, Kuramochi M, Matsuoka H, Omae T.

Hypertens Res. 1997 Mar;20(1):23-8.

 

27. A case of splenic artery aneurysm with Cushing's syndrome.

Yoshitomi Y, Yoshimi H, Yutani C.

Int J Cardiol. 1996 Jun;54(3):263-5.

 

28. Comparison of changes in cardiac structure after treatment in secondary hypertension.

Yoshitomi Y, Nishikimi T, Abe H, Yoshiwara F, Suzuki T, Ashizawa A, Nagata S, Kuramochi M, Matsuoka H, Omae T.

Hypertension. 1996 Mar;27(3 Pt 1):319-23.

 

英文共著論文


1. Primary cardiac lymphoma--a case report.

Saotome M, Yoshitomi Y, Kojima S, Kuramochi M.

Angiology. 2002 Mar-Apr;53(2):239-41.

 

2. Dilated cardiomyopathy of Becker-type muscular dystrophy with exon 4 deletion--a case report.

Saotome M, Yoshitomi Y, Kojima S, Kuramochi M.

Angiology. 2001 May;52(5):343-7.

 

3. Long-term follow-up of primary stenting with coil stent in acute myocardial infarction.

Yano M, Yoshitomi Y, Kojima S, Sugi T, Matsumoto Y, Kuramochi M.

Angiology. 2000 Feb;51(2):107-14.

 

4. Heterogeneity of renal cortical circulation in hypertension assessed by dynamic computed tomography.

Kojima S, Yoshitomi Y, Yano M, Saotome M, Tanaka K, Endo M, Kuramochi M.

Am J Hypertens. 2000 Apr;13(4 Pt 1):346-52.

 

5. Effects of losartan on low-density lipoprotein apheresis.

Kojima S, Yoshitomi Y, Saotome M, Tanaka K, Shida M, Kuramochi M.

Ther Apher. 1999 Nov;3(4):303-6.

 

6. Plasma adrenomedullin as an indicator of prognosis after acute myocardial infarction.

Nagaya N, Nishikimi T, Uematsu M, Yoshitomi Y, Miyao Y, Miyazaki S, Goto Y, Kojima S, Kuramochi M, Matsuo H, Kangawa K, Nonogi H.

Heart. 1999 May;81(5):483-7.

 

7. Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.

Kojima S, Yoshitomi Y, Sugi T, Matsumoto Y, Yano M, Kuramochi M.

Ther Apher. 1998 Nov;2(4):263-7.

 

8. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.

Kojima S, Ogi M, Sugi T, Matsumoto Y, Yoshitomi Y, Kuramochi M.

Ther Apher. 1997 Nov;1(4):356-61.

 

9. A close association between brain lacuna infarction and renal surface irregularity.

Kojima S, Ogi M, Yoshitomi Y, Sugiyama A, Katayama M, Kuramochi M.

Am J Hypertens. 1997 Dec;10(12 Pt 1):1378-83.

 

10. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.

Kojima S, Ogi M, Yoshitomi Y, Kuramochi M, Ikeda J, Naganawa M, Hatakeyama H.

Int J Artif Organs. 1997 Mar;20(3):178-83.

 

11. Left ventricular structural and functional characteristics in patients with renovascular hypertension, primary aldosteronism and essential hypertension.

Yoshihara F, Nishikimi T, Yoshitomi Y, Nakasone I, Abe H, Matsuoka H, Omae T.

Am J Hypertens. 1996 Jun;9(6):523-8.

 

12.Time course of bradykinin generation during LDL apheresis.

Kojima S, Iwase N, Yoshitomi Y, Ogi M, Osada M, Iimuro M, Kuramochi M.

Jpn J Apheresis. 1996;15(1):126-7.

 

13. Changes in bradykinin and other vasoactive factors during LDL apheresis.

Kojima S, Iwase N, Yoshitomi Y, Ogi M, Osada M, Iimuro M, Kuramochi M.

Jpn J Apheresis. 1996;15(1):124-5.

 

14. Glomerular hemodynamics during supraventricular tachycardia.

Kojima S, Fujii T, Ohe T, Yoshitomi Y, Kuramochi M, Shimomura K, Omae T.

Jpn Heart J. 1995 Jul;36(4):429-37.

 

15. Comparison of first-line antihypertensive drugs by a randomized cross-over method--a preliminary report.

Kojima S, Kawano Y, Yoshitomi Y, Kuramochi M, Matsuoka H, Omae T.

Hypertens Res. 1995 Dec;18(4):303-5.

 

和文論文

 

1. 急性心筋梗塞発症早期からのBeta遮断薬の使用経験

  吉冨雄治、矢野理子、杉敏彦、松本雄二、早乙女雅夫、遠藤路子、倉持衛夫、小嶋俊一

  薬理と治療 1999;27:217-223.

 

2. 急性心筋梗塞症に対するβ遮断薬ビソプロロールの長期投与

  吉冨雄治、小嶋俊一、矢野理子、杉敏彦、松本雄二、早乙女雅夫、遠藤路子、倉持衛夫

  Progress in Medicine 1999;19:151-6.

 

3. ACE阻害薬イミダプリルの心筋梗塞後リモデリング抑制効果

  吉冨雄治、小嶋俊一、矢野理子、杉敏彦、松本雄二、早乙女雅夫、遠藤路子、倉持衛夫

  薬理と治療 1998;26:221-8.

 

4. 心筋梗塞後リモデリングに対するACE阻害薬イミダプリルの効果についての検討

  吉冨雄治、小嶋俊一、矢野理子、杉敏彦、松本雄二、倉持衛夫

  Progress in Medicine 1998;18:171-5.

 

5. 透析導入期に両眼性の網膜静脈閉塞症を認めた1症例

  吉冨雄治、木村玄次郎、松岡博昭、笹岡厚子

  腎と透析 1993;34:171-4.

 

6. 慢性血液透析中に薬剤誘発性心室頻拍を起こした1症例

  吉冨雄治、品川亮、木村玄次郎、小嶋俊一、松岡博昭

  透析会誌 1993;26:1807-10.

 

7. 亜急性滲出性収縮性心膜炎と考えられる1臨床例

  吉冨雄治、片山知之、本田幸治、古川浩一郎、小笠原長正、峯豊、入江準二、竹林茂夫

  呼吸と循環 1992;40:289-93.

 

8. 高血圧(上巻)心疾患-概論

  吉冨雄治、阿部仁

  日本臨床 1992;50:557-63.